Scenarios that move GKOS

Glaukos Corporation Common Stock

Scenarios that move GKOS: 1 analysis, 1 positive, 0 negative.

  1. · Opus Genetics receives FDA approval for presbyopia eye drop — ▲ · impact +8 · confidence low · horizon weeks

All scenarios · Run a scenario · Pricing